SUIT protocol library: Difference between revisions

From Bioblast
No edit summary
Β 
(63 intermediate revisions by 6 users not shown)
Line 1: Line 1:
== CI ==
{{MitoPedia
|abbr=SUITs
|description=The '''Substrate-uncoupler-inhibitor titration (SUIT) protocol library''' contains a sequential list of SUIT protocols (D001, D002, ..) with links to the specific SUIT pages. Classes of [[SUIT|SUIT protocols]] are explained with coupling and substrate control defined for [[mitochondrial preparations]].
|info=[[MitoPedia: SUIT]]
}}
__TOC__


== CII ==
== List of SUIT numbers ==


== CI+CII ==
{{#ask:[[MitoPedia concept::MiP concept]] [[MitoPedia concept::SUIT protocol]]
| mainlabel=SUIT code
| format=broadtable
| limit=5000
| order=ascending
}}




== List of SUIT protocols with D-numbers ==
{{#ask:[[MitoPedia concept::SUIT protocol]] [[MitoPedia concept::Find]]
| ?Has SUIT number=SUIT technical name
| mainlabel=SUIT code
| format=broadtable
| limit=5000
| order=ascending
}}


== CI - CI+CII - CII ==
== Strategy ==
:::# [[#Define pathway states |Define substrates and inhibitors]] for each pathway state.
:::# [[#Define coupling states |Define coupling states]].


=== GM+D+S+F+Rot ===


# GM+D+c+S+F+Rot: [[Cytochrome_c|cyt c]] added after ADP ([[Boushel 2007 Diabetologia]])
== Definition of states ==
# GM+D+S+c+F+Rot: cyt c added after S


* ADP conc:
=== Experimental conditions ===
* ROX: Ama ([[Boushel 2007 Diabetologia]])
:::* Temp
:::* O2
:::* Medium
:::* Oxygen level
:::* ADP kinetics
:::* Substrate kinetics


=== GM+D+P+S+F+Rot ===
=== O2k configuration ===
:::* Amp: Amplex Red, TMRM, Ca Green, ...
:::* Pot
:::* Spectrophotometry


# ''Innsbruck protocol 1'': GM+D+c+P+S+F+Rot:


* Respiratory states: CI(L) - CI(P) - CI+II(P) - CI+II(E) - CII(E)Β  - ROX
=== Define pathway states ===
* [[Cytochrome c|''Cyt c'']]: early addition of ''c'' ensures comparability of all states in case of any ''c'' effect
:::: [[Pathway control state]]s are defined for many substrate-inhibitor combinations in SUIT protocols, particularly: ([[N-pathway control state]], [[S-pathway control state]], [[NS-pathway control state]]). Titrations may performed in a single step, or in multiple steps for sequential analyis of different pathway control states.
* ([[Gnaiger_2007_MitoPathways]])


=== PM+D+G+S+F+Rot ===
:::* N: PM, GM, PGM, M, ..
:::* S: S(Rot), S, SM, ..
:::* NS: PS, GS, PMS, GMS, PGMS, ..
:::* CIV: AsTM
:::* F: Oct, Pal, ...
:::* Gp


# ''Innsbruck protocol 2'': PM+D+c+G+S+F+RotΒ 


* Respiratory states: CI(L) - CI(P) - CI+II(P) - CI+II(E) - CII(E) - ROX
=== Define coupling states ===
* ([[Gnaiger_2007_MitoPathways]])
:::: The [[coupling-control state]]s require a complementary definition of an [[ET-pathway competent state]].
:::* ''L'', ''P'', ''E'' ([[Uncoupler]]s, U: FCCP, CCCP, DNP)
Coupling states: [[Image:L.jpg|link=LEAK respiration|LEAK]] [[Image:P.jpg|link=OXPHOS capacity|OXPHOS]] [[Image:E.jpg|link=ET capacity|ET capacity]]


=== PMG+D+S+F+Rot ===


# PMG+D+c+S+F+Rot
=== Define residual oxygen consumption ===
:::* ROX: Rot&Ama, Rot&Mna&Ama, Myx, Cn, Az, ..
[[Image:ROX.jpg|link=Residual oxygen consumption|ROX]]


* Respiratory states: CI(L) - CI(P) - CI+II(P) - CI+II(E) - CII(E)


* ADP conc: in mouse brain homogenate a final conc. of 2 mM ADP in the [[OXPHOS]] state (CI+CII) is saturating ([[Sumbalova_2011_Abstract]])
== Categories of SUIT protocolsΒ  ==
* [[ROX]]: Mna+Ama; Myx ([[Gnaiger_2009_IJBCB]])
:::Β» [[Categories of SUIT protocols]]
:::Β» [[Talk:SUIT protocol library]]


== ETF + CI ==
== SUIT protocol patterns ==


:::Β» [[SUIT protocol pattern]]


== ETF + CI + CII ==


== Examples of SUIT protocols ==


== CIV ==
=== N; NS; S diametral ===


:::: Old nomenclature: CI + CI<small>&</small>II + CII diametral
:::: Respiratory states: N<sub>''L''</sub> -> N<sub>''P''</sub> -> NS<sub>''P''</sub> -> NS<sub>''E''</sub> -> S<sub>''E''</sub> -> ROX


== ADP kinetics ==
::::* '''GM;D;S;U;Rot''' ''Innsbruck-Copenhagen protocol'': GM;D;c;S;U;Rot ::Cyt ''c'': added after ADP; cyt ''c'' added after S; ADP conc: _ _; ROX: Ama ([[Boushel 2007 Diabetologia]])


== cytochrome c ==
::::* '''PMG;D;S;U;Rot''' ''Brain protocol'': PGM;D;c;S;U;Rot::ADP conc: in mouse brain homogenate a final conc. of 2 mM ADP in the NS-[[OXPHOS]] state (NS<sub>''P''</sub>) is saturating ([[Sumbalova 2011 Abstract Bordeaux]]); [[ROX]]: Mna&Ama; Myx




== ROX ==
=== N; N; NS; S diamteral ===


== Abbreviations ==
:::: Old nomenclature: CI + CI + CI<small>&</small>II + CII diamteral
::::* '''GM;D;P;S;U;Rot''' ''Innsbruck-Liege protocol 1'': GM;D;c;P;S;U;Rot::[[Cytochrome c]]: early addition of ''c'' ensures comparability of all states in case of any ''c'' effect.


* [[List_of_respiratory_states]]
::::* '''PM;D;G;S;U;Rot''' ''Innsbruck-Liege protocol 2'': PM;D;c;G;S;U;Rot
* [[List_of_terms_and_abbreviations]]
Β 
Β 
=== F; FN; FNS; S diametral ===
Β 
:::: Old nomenclature: FAO + CI + CI<small>&</small>II + CII diametral
:::: Respiratory states: F<sub>''L''</sub> -> F<sub>''P''</sub> -> FN<sub>''P''</sub> -> FNS<sub>''P''</sub> -> FNS<sub>''E''</sub> -> S''E''</sub> -> ROX
Β 
::::* '''OctM;D;G;S;U;Rot''' ''Innsbruck training protocol'': OctM;D;G;c;S;U;Rot::[[Pesta 2012 Methods Mol Biol]], [[Pesta 2011 Am J Physiol Regul Integr Comp Physiol]]
Β 
Β 
:::: Respiratory states: F<sub>''L''</sub> -> F<sub>''P''</sub> -> FN<sub>''P''</sub> -> FNS<sub>''P''</sub> -> S<sub>''P''</sub> -> S<sub>''L''</sub> -> S<sub>''E''</sub> -> ROX
Β 
::::* '''OctM;D;G;S;Rot;Omy;U''' ''Greenland-Monte Rosa protocol'': OctM;D;G;S;Rot;Omy;U;c::[[Cytochrome c|Cyt ''c'']]: added after U. The absence of a significant ''c''-effect shows the integrity of the outer mitochondrial membrane after fibre preparation and also shows the preservation of integrity over a 90-100 min incubation in the O2k ([[MiR05]]); Oxygen: oxygen limitation of flux was preventd by maintaining oxygen levels in the respirometer above air saturation ([[Pesta 2012 Methods Mol Biol]]); [[ROX]]: Mna&Ama
Β 
Β 
== References and notes ==
Β 
:::* [[MitoPedia: Respiratory states]]
:::* [[MitoPedia: Terms and abbreviations]]
Β 
::::* [[Doerrier 2018 Methods Mol Biol]]
::::* [[Gnaiger_2014_MitoPathways]]
::::* [[Gnaiger_2009_Int J Biochem Cell Biol]]
::::* [[Pesta 2012 Methods Mol Biol]]
::::* [[Pesta 2011 Am J Physiol Regul Integr Comp Physiol]]
Β 
{{MitoPedia concepts
|mitopedia concept=MiP concept, SUIT concept
}}
{{MitoPedia methods}}
{{MitoPedia O2k and high-resolution respirometry}}
{{MitoPedia topics}}

Latest revision as of 15:01, 8 June 2020


high-resolution terminology - matching measurements at high-resolution


SUIT protocol library

Description

[[Description::The Substrate-uncoupler-inhibitor titration (SUIT) protocol library contains a sequential list of SUIT protocols (D001, D002, ..) with links to the specific SUIT pages. Classes of SUIT protocols are explained with coupling and substrate control defined for mitochondrial preparations.]]

Abbreviation: SUITs

Reference: [[Info::MitoPedia: SUIT]]

List of SUIT numbers

SUIT code
SUIT-001
SUIT-002
SUIT-003
SUIT-004
SUIT-005
SUIT-006
SUIT-007
SUIT-008
SUIT-010
SUIT-011
SUIT-012
SUIT-013
SUIT-014
SUIT-015
SUIT-016
SUIT-017
SUIT-018
SUIT-019
SUIT-020
SUIT-021
SUIT-022
SUIT-024
SUIT-025
SUIT-027
SUIT-031


List of SUIT protocols with D-numbers

SUIT codeSUIT technical name
SUIT-001 O2 ce-pce D003D003_ce1;1Dig;1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp;9Ama;10AsTm;11Azd
SUIT-001 O2 ce-pce D004D004_ce1;1Dig;1PM;2D;2c;3U;4G;5S;(6Oct);7Rot;8Gp;9Ama;10AsTm;11Azd
SUIT-001 O2 mt D001D001_mt;1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp;9Ama;10AsTm;11Azd
SUIT-001 O2 pfi D002D002_pfi;1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp;9Ama;10AsTm;11Azd
SUIT-002 O2 ce-pce D007D007_ce1;1Dig;1D;2M;3Oct;3c;4M;5P;6G;7S;8Gp;9U;10Rot;11Ama;12AsTm;13Azd
SUIT-002 O2 ce-pce D007aD007a_ce1;1Dig;1D;2M;3Oct;3c;4M;5P;6G;7S;8Gp;9U;10Rot;11Ama;12AsTm;13Azd
SUIT-002 O2 mt D005D005_mt;1D;2M;3Oct;3c;4M;5P;6G;7S;8Gp;9U;10Rot;11Ama;12AsTm;13Azd
SUIT-002 O2 pfi D006D006_pfi;1D;2M.1;3Oct;3c;4M2;5P;6G;7S;8Gp;9U;10Rot;11Ama;12AsTm;13Azd
SUIT-003 AmR ce D017D017_ce1;ce2P;ce3Omy;ce4U;ce5Rot;ce6S;ce7Ama
SUIT-003 AmR ce D058D058_ce1;ce1SOD;ce1HRP;ce1AmR;ce2Omy;ce3U;ce4Rot;ce5Ama
SUIT-003 AmR ce D059D059_ce1;ce1H2O;ce1MiR05;ce1DMSO;ce2Omy;ce3U;ce4Rot;ce5Ama
SUIT-003 O2 ce D009D009_ce1;ce2Omy;ce3U;ce4Ama
SUIT-003 O2 ce D012D012_ce1;ce1P;ce2Omy;ce3U;ce4Rot;ce5Ama
SUIT-003 O2 ce D028D028_ce1;ce2Omy;ce3U;ce4Rot;ce5S;ce6Ama
SUIT-003 O2 ce D037D037_ce1;ce1Glc;(ce2Omy);ce3U;ce4Ama
SUIT-003 O2 ce D038D038_ce1;(ce2Omy);ce3U;ce3Glc;ce3'U;ce4Ama
SUIT-003 O2 ce D039D039_ce1;(ce2Omy);ce3U;ce4Rot;ce5Ama
SUIT-003 O2 ce D050D050_ce1;ce1Snv;(ce2Omy);ce3U;ce4Rot;ce5Ama
SUIT-003 O2 ce D060D060_ce1;(ce2Omy);ce3U;ce4Rot;ce5Snv;ce6Mnanv;ce7Ama
SUIT-003 O2 ce D061D061_ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama
SUIT-003 O2 ce D062D062_ce1;ce1DMSO;(ce2Omy);ce3U;ce4Rot;ce5Ama
SUIT-003 O2 ce-pce D013D013_ce1;ce1P;ce2Omy;ce3U;ce3Glc;ce3M;ce4Rot;ce5S;1Dig;1U;1c;2Ama;3AsTm;4Azd
SUIT-003 O2 ce-pce D018D018_ce1;ce1P;ce2Omy;ce3U;ce3Glc;ce4Rot;ce5S;1Dig;1c;2Ama;3AsTm;4Azd
SUIT-003 O2 ce-pce D020D020_ce1;ce1P;ce2Omy;ce3U;ce4Rot;ce5S;1Dig;1c;2Ama;3AsTm;4Azd
SUIT-003 pH ce D067D067_ce1;ce1Glc;ce2Omy;ce3DG;ce4Ama
SUIT-004 O2 pfi D010D010_1PM;2D;2c;3U;4S;5Rot;6Ama;7AsTm;8Azd
SUIT-005 O2 pfi D011D011_1OctM;2D;2c;3P;4S;5U;6Rot;7Ama;8AsTm;9Azd
SUIT-006 AmR mt D048D048_1PM;2D;3Omy;4U;5Ama
SUIT-006 Fluo mt D034D034_1PM;2D;3Omy;4U;5Ama
SUIT-006 MgG ce-pce D085D085_ce1;1Dig;1PM;2D;3Cat;4U;5Ama
SUIT-006 MgG mt D055D055_1PM;2D;3Cat;4U;5Ama
SUIT-006 O2 ce-pce D029D029_ce1;1Dig;1PM;2D;2c;3Omy;4U;5Ama
SUIT-006 O2 mt D022D022_1SRot;2D;2c;(3Omy);4U;5Ama
SUIT-006 O2 mt D047D047_1PM;2D;2c;3Omy;4U;5Ama
SUIT-006 Q ce-pce D073D073_ce1;1Dig;1Q2;1Rot;1S;2D;(3Omy);4U;5Anox;6Ama.png
SUIT-006 Q mt D071D071_mt;1Q2;1Rot;1S;2D;(3Omy);4U;5Anox;6Ama.png
SUIT-007 O2 ce-pce D030D030_ce1;1Dig;1G;2D;2c;3M;4U;5Ama
SUIT-008 O2 ce-pce D025D025_ce1;1Dig;1PM;2D;2c;3G;4S;5U;6Rot;7Ama;8AsTm;9Azd
SUIT-008 O2 mt D026D026_1PM;2D;2c;3G;4S;4D;5U;6Rot;7Ama;8AsTm;9Azd
SUIT-008 O2 pfi D014D014_1PM;2D;2c;3G;4S;4D;5U;6Rot;7Ama;8AsTm;9Azd
SUIT-009 AmR ce-pce D019D019_ce1;1Dig;1S;2D;3P;4Rot;5Ama
SUIT-009 AmR mt D021D021_1S;2D;3P;4Rot;5Ama
SUIT-009 O2 ce-pce D016D016_ce1;1Dig;1S;2D;3P;4Rot;5Ama
SUIT-009 O2 mt D015D015_1S;2D;3P;4Rot;5Ama
SUIT-010 O2 ce-pce D008D008_ce1;ce2Rot;ce3S;ce4D;1Dig;1c
SUIT-011 O2 pfi D024D024_1GM;2D;2c;3S;4U;5Rot;6Ama
SUIT-012 O2 ce-pce D052D052_ce1;1Dig;1PM;2D;2c;3G;4U;5Ama
SUIT-012 O2 mt D027D027_1PM;2D;2c;3G;4U;5Ama
SUIT-013 AmR ce D023D023_ce1
SUIT-014 O2 pfi D042D042_1GM;2D;2c;3P;4S;5U;6Rot;7Ama
SUIT-015 O2 pti D043D043_1OctM;2D;2c;3G;4P;5S;6U;7Rot;8Ama
SUIT-016 O2 pfi D044D044_1OctM;2D;3G;4S;5Rot;6Omy;7U;8Ama
SUIT-017 O2 mt D046D046_1OctM;2D;2c;3G;3c;4S;5U;6Rot;7Ama
SUIT-017 O2 pfi D049D049_1OctM;2D;2c;3G;4S;5U;6Rot;7Ama
SUIT-018 AmR ce-pce D068D068_ce1;1Dig;1GMS;2D;3Ama
SUIT-018 AmR mt D031D031_mt;1GMS;2D;3Ama
SUIT-018 AmR mt D040D040_mt;1GMS;2D;3Ama
SUIT-018 AmR mt D041D041_mt;1GMS;2D;3Ama
SUIT-018 O2 mt D054D054_mt;1GMS;2D;2c;3Ama
SUIT-019 O2 pfi D045D045_1PalM;2D;2c;3Oct;4P;5G;6U;7S;8Rot;9Ama
SUIT-020 Fluo mt D033D033_1PM;2D;3G;4S;5Rot;6Omy;7U;8Ama
SUIT-020 O2 mt D032D032_1PM;2D;2c;3G;4S;5Rot;6Omy;7U;8Ama
SUIT-021 Fluo mt D036D036_1GM;2D;3S;4Rot;5Omy;6U;7Ama
SUIT-021 O2 mt D035D035_1GM;2D;2c;3S;4Rot;5Omy;6U;7Ama
SUIT-022 O2 ce D051D051_ce1;ce2KCN;ce3SHAM
SUIT-023 O2 ce D053D053_ce1;ce2SHAM;ce3KCN
SUIT-024 O2 ce-pce D056D056_ce1;1Dig;1PM;2T;2D;3Omy;4Ama
SUIT-025 O2 mt D057D057_1D;2M;3Oct;3c;4M;5P;6G;7S;8Rot;9Ama
SUIT-026 AmR ce-pce D087D087_ce1;1Dig;1S;2Rot;3D;4Ama
SUIT-026 AmR mt D064D064_1S;2Rot;3D;4Ama
SUIT-026 AmR mt D077D077_1S;2Rot;3D;4Ama
SUIT-026 O2 ce-pce D088D088_ce1;1Dig;1S;2Rot;3D;3c;4Ama
SUIT-026 O2 mt D063D063_1S;2Rot;3D;3c;4Ama
SUIT-027 O2 ce-pce D065D065_ce1;1Dig;1M;2D;3M;4P;5G
SUIT-029 O2 mt D066D066_mt;1PM;2T;2D;2c;3Omy;4U;5G;6S;6U;7Rot;8Ama
SUIT-031 O2 ce-pce D079D079_ce1;1Dig;1PM;2D;2c;3S;4Rot;5U;6Ama
SUIT-031 O2 mt D075D075_1mt;1PM;2D;2c;3S;4Rot;5U;6Ama
SUIT-031 Q ce-pce D074D074_ce1;1Dig;1Q2;1PM;2D;3S;4Rot;5U;6Anoxia;7Ama
SUIT-031 Q mt D072D072_mt;1Q2;1PM;2D;3S;4Rot;5U;6Anox;7Ama

Strategy

  1. Define substrates and inhibitors for each pathway state.
  2. Define coupling states.


Definition of states

Experimental conditions

  • Temp
  • O2
  • Medium
  • Oxygen level
  • ADP kinetics
  • Substrate kinetics

O2k configuration

  • Amp: Amplex Red, TMRM, Ca Green, ...
  • Pot
  • Spectrophotometry


Define pathway states

Pathway control states are defined for many substrate-inhibitor combinations in SUIT protocols, particularly: (N-pathway control state, S-pathway control state, NS-pathway control state). Titrations may performed in a single step, or in multiple steps for sequential analyis of different pathway control states.
  • N: PM, GM, PGM, M, ..
  • S: S(Rot), S, SM, ..
  • NS: PS, GS, PMS, GMS, PGMS, ..
  • CIV: AsTM
  • F: Oct, Pal, ...
  • Gp


Define coupling states

The coupling-control states require a complementary definition of an ET-pathway competent state.

Coupling states: LEAK OXPHOS ET capacity


Define residual oxygen consumption

  • ROX: Rot&Ama, Rot&Mna&Ama, Myx, Cn, Az, ..

ROX


Categories of SUIT protocols

Β» Categories of SUIT protocols
Β» Talk:SUIT protocol library

SUIT protocol patterns

Β» SUIT protocol pattern


Examples of SUIT protocols

N; NS; S diametral

Old nomenclature: CI + CI&II + CII diametral
Respiratory states: NL -> NP -> NSP -> NSE -> SE -> ROX
  • GM;D;S;U;Rot Innsbruck-Copenhagen protocol: GM;D;c;S;U;Rot ::Cyt c: added after ADP; cyt c added after S; ADP conc: _ _; ROX: Ama (Boushel 2007 Diabetologia)
  • PMG;D;S;U;Rot Brain protocol: PGM;D;c;S;U;Rot::ADP conc: in mouse brain homogenate a final conc. of 2 mM ADP in the NS-OXPHOS state (NSP) is saturating (Sumbalova 2011 Abstract Bordeaux); ROX: Mna&Ama; Myx


N; N; NS; S diamteral

Old nomenclature: CI + CI + CI&II + CII diamteral
  • GM;D;P;S;U;Rot Innsbruck-Liege protocol 1: GM;D;c;P;S;U;Rot::Cytochrome c: early addition of c ensures comparability of all states in case of any c effect.
  • PM;D;G;S;U;Rot Innsbruck-Liege protocol 2: PM;D;c;G;S;U;Rot


F; FN; FNS; S diametral

Old nomenclature: FAO + CI + CI&II + CII diametral
Respiratory states: FL -> FP -> FNP -> FNSP -> FNSE -> SE -> ROX


Respiratory states: FL -> FP -> FNP -> FNSP -> SP -> SL -> SE -> ROX
  • OctM;D;G;S;Rot;Omy;U Greenland-Monte Rosa protocol: OctM;D;G;S;Rot;Omy;U;c::Cyt c: added after U. The absence of a significant c-effect shows the integrity of the outer mitochondrial membrane after fibre preparation and also shows the preservation of integrity over a 90-100 min incubation in the O2k (MiR05); Oxygen: oxygen limitation of flux was preventd by maintaining oxygen levels in the respirometer above air saturation (Pesta 2012 Methods Mol Biol); ROX: Mna&Ama


References and notes


MitoPedia concepts: MiP concept, SUIT concept 






Cookies help us deliver our services. By using our services, you agree to our use of cookies.